Announcements Trials
Browse Landscape

Phase

Phase NA 88Phase 2 43Phase 1/2 13Phase 3 9Phase 1 9Phase EARLY_PHASE1 5Phase 4 3Phase 2/3 1

Status

Completed 41Recruiting 17Unknown 14Active not recruiting 10Terminated 8Withdrawn 7Not yet recruiting 5Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5Breast 1

Conditions

Multiple Myeloma 12Recurrence 9Neoplasms 8Leukemia, Myeloid, Acute 7Hematologic Neoplasms 7Colorectal Neoplasms 7Pancreatic Neoplasms 6Lymphoma, B-Cell 6Carcinoma, Hepatocellular 6Breast Neoplasms 6Sarcoma 5Prostatic Neoplasms 5Lymphoma 5Burkitt Lymphoma 5Neoplasms, Plasma Cell 4Myasthenia Gravis 4Lung Neoplasms 4Glioblastoma 4Brain Neoplasms 4Stomach Neoplasms 3Solid Tumor 3Pituitary Neoplasms 3Ovarian Neoplasms 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Head and Neck Neoplasms 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Not yet recruiting × Prostatic Neoplasms × Clear all
NCT07608848 2026-05-27

DOTA-STR-17126

Integrated Haematology and Oncology Network

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
BreastGenitourinary

Breast Neoplasms, Neoplasms, Prostatic Neoplasms

NCT07542379 2026-04-21

The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

FindCure Biosciences (ZhongShan) Co., Ltd.

Phase EARLY_PHASE1 Not yet recruiting
13 enrolled
Genitourinary

Prostatic Neoplasms

NCT07516704 2026-04-08

Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study

Zhongda Hospital

Phase EARLY_PHASE1 Not yet recruiting
94 enrolled
Genitourinary

Prostatic Neoplasms

NCT07381582 2026-02-02

161Tb-LNC1011

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Not yet recruiting
15 enrolled
Genitourinary

Prostatic Neoplasms

NCT06546527 2024-08-09

Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer(mCRPC)

Peking University First Hospital

Phase EARLY_PHASE1 Not yet recruiting
12 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡